HIGHLIGHTS
- who: Benjamin C. Park from the therapy who received serial PET-CT scans at the Vanderbilt University Medical Center (VUMC)Primary outcomes have published the Article: Immune checkpoint inhibitors and their impact on liver enzymes and attenuation, in the Journal: (JOURNAL)
- what: The study aims to determine whether ICI therapy affects liver attenuation and liver enzymes in melanoma patients with and without hepatic steatosis. The analysis demonstrates that ICIs do not appear to worsen Note.
- future: The pathogenesis of this process even outside the context of ICI therapy is poorly understood and further . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.